30 June 2011
Cobra Biologics Holding AB acquires Recipharm AB’s shares in RecipharmCobra Biologics
20 June 2011
Continuation of Partnership in the Development of KAHR-102
02 February 2011
Patents Granted on Bacterial Genetic Modification Technology (Xer-cise™)
13 January 2011
Successful Pre-Clinical TB Vaccine Results using Oral Vaccine Delivery Platform (ORT-VAC™)
For further information, please contact:
Julian Hanak
Commercial Services
Tel: +44 (0) 1782 714 181